Vascular remodeling and arterial calcification are directly mediated by S100A12 (EN-RAGE) in chronic kidney disease

Joseph Gawdzik1, Liby Mathew, Gene Kim

  • 1Sections of Cardiology, Department of Medicine, University of Chicago, IL 60637, USA.

Insights

The proinflammatory cytokine S100A12 (EN-RAGE) promotes vascular calcification in chronic kidney disease (CKD). This study shows S100A12 exacerbates CKD-induced vascular osteogenesis and calcification in mice via RAGE activation and oxidative stress.

Area of Science:

  • Cardiovascular Biology
  • Nephrology
  • Vascular Biology

Background:

  • The proinflammatory cytokine S100A12 (EN-RAGE) is linked to cardiovascular issues in hemodialysis patients.
  • This study investigates S100A12's role in vascular disease development under chronic kidney disease (CKD) conditions.

Purpose of the Study:

  • To test if S100A12 expression in vascular smooth muscle contributes to vascular disease in a CKD mouse model.
  • To elucidate the mechanisms by which S100A12 influences vascular calcification in CKD.

Main Methods:

  • Chronic kidney disease (CKD) was induced in S100A12 transgenic and wild-type mice via ureter ligation.
  • Aortic tissues and cultured aortic smooth muscle cells were analyzed after 7 weeks of elevated blood urea nitrogen (BUN).

Main Results:

  • S100A12 transgenic mice exhibited enhanced vascular medial calcification compared to wild-type mice with CKD.
  • Vascular calcification involved the S100A12 receptor, RAGE (receptor for advanced glycation endproducts), and oxidative stress.
  • Inhibiting NADPH-oxidase Nox1 or RAGE signaling attenuated calcification and osteoblastic gene expression in cultured cells.

Conclusions:

  • S100A12 significantly augments CKD-triggered vascular osteogenesis in mice.
  • These findings mirror vascular calcification observed in human CKD and end-stage kidney disease patients.
Abstract

Related Concept Videos

Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Osteoclasts in Bone Remodeling01:31

Osteoclasts in Bone Remodeling

Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during bone...
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...